Actively Recruiting

Phase Not Applicable
Age: 18Years - 50Years
FEMALE
NCT07021846

Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer

Led by Fondazione Policlinico Universitario Campus Bio-Medico · Updated on 2025-06-15

132

Participants Needed

1

Research Sites

520 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this prospective, single-arm, phase II, non-randomized trial is to evaluate an hypofractionation schedule with high dose simultaneous integrated tumor bed boost in early breast cancer patients. The main question\[s\] it aims to answer are: * evaluate the rate of all grades of radiation-induced fibrosis at 4 years. * evaluate poor/fair cosmesis rate Participants will be treated with hypofractionated radiotherapy (RT) to whole breast with a dose of 40.05 Gy in 15 fractions (2.67 Gy/die) and a concomitant tumor bed dose of 52.5 Gy (3.5 gy/die)

CONDITIONS

Official Title

Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer

Who Can Participate

Age: 18Years - 50Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically confirmed breast cancer treated with conservative surgery
  • At least 3 surgical clips inserted
  • Age between 18 and 50 years
  • Presence of at least one risk factor: N1 disease, lymphovascular invasion, extensive intraductal component (>25%), close margins (<4 mm), non-hormone-sensitive disease, or grade 3 tumor
  • ECOG performance status less than 2
  • Adequate bone marrow function with hemoglobin > 8 g/dl, white blood cell count > 3000/mm3, platelet count > 75000
Not Eligible

You will not qualify if you...

  • Previous radiation treatment to the chest
  • Bilateral breast cancer
  • Neoadjuvant chemotherapy
  • Body mass index over 35
  • Collagen diseases
  • Pregnancy or breastfeeding

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Università Campus Biomedico

Roma, Italy

Actively Recruiting

Loading map...

Research Team

E

Edy Ippolito, Prof

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer | DecenTrialz